logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Xintai Medical (02291.HK) spent HKD 308,000 on October 9 to repurchase 23,000 shares.

date
09/10/2026
Zhito Finance APP News: Xintai Medical (02291.HK) announced that on October 9, 2026, it spent HK$308,000 to repurchase 23,000 shares.
Latest
2 m ago
Ningbo Port (601018.SH): Estimated container throughput for September reached 5.07 million TEUs, up 9.3% year on year.
5 m ago
China Shenhua (01088.HK): Zhuang Yuan appointed as authorized representative
6 m ago
China Sante (00910): He Yongshen Appointed as Independent Non-Executive Director
7 m ago
China Liberal Education (01769.HK): Trustee purchased a total of 158,000 shares under the share award scheme.
7 m ago
Tangshan Port (601000.SH): January-September cumulative cargo throughput is expected to reach 189 million tons, a year-on-year increase of 5.06%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.